Respiratory Drug Market Revenue 2024 to 2034
Respiratory Drug Market Revenue 2024 to 2034
The respiratory drug market, worth USD 17.53 billion in 2024, is projected to reach USD 30.80 billion by 2034 at a CAGR of 5.8%, driven by rising cases of asthma, COPD, and lung-related disorders.
Report ID: 10467
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 17.53 Bn
Forecast Year,
USD 30.81 Bn
CAGR, 2025 -
5.80%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Respiratory Drug Market Size Analysis
Respiratory Drug Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| COPD | 11.71 | 11.64 | 11.81 | 12.38 | 13.14 | 13.59 | 14.37 | 16.21 | 16.93 | 16.93 | 17.13 |
| Asthma | 2.79 | 3.18 | 4.20 | 4.69 | 4.86 | 5.51 | 5.22 | 5.03 | 5.29 | 6.16 | 6.92 |
| Allergic Rhinitis | 0.37 | 0.34 | 0.20 | 0.21 | 0.21 | 0.24 | 0.69 | 0.27 | 0.27 | 0.61 | 1.38 |
| Other Respiratory | 2.66 | 3.39 | 3.41 | 3.48 | 3.75 | 3.90 | 4.30 | 4.50 | 5.04 | 5.42 | 5.38 |
Respiratory Drug Market Size By Class 2024 to 2034 (USD )
| Class | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bronchodilators | 1.74 | 1.69 | 1.68 | 1.39 | 1.39 | 1.68 | 1.29 | 1.17 | 1.52 | 2.16 | 1.70 |
| Corticosteroids | 1.67 | 1.89 | 1.51 | 1.85 | 2.18 | 2.08 | 2.62 | 2.94 | 2.71 | 2.51 | 1.42 |
| Combination Therapies | 5.09 | 5.36 | 6.00 | 6.05 | 6.84 | 6.96 | 7.18 | 7.57 | 7.12 | 8.21 | 9.28 |
| Biologics | 3.52 | 3.98 | 4.59 | 5.32 | 5.55 | 5.99 | 6.70 | 7.07 | 8.08 | 7.67 | 9.59 |
| Other | 5.52 | 5.63 | 5.83 | 6.14 | 6.01 | 6.52 | 6.80 | 7.26 | 8.09 | 8.57 | 8.82 |
Respiratory Drug Market Size By Route 2024 to 2034 (USD )
| Route | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhalation | 2.48 | 2.80 | 2.34 | 2.72 | 3.09 | 3.26 | 3.49 | 3.62 | 3.54 | 4.51 | 4.12 |
| Oral | 5.51 | 5.88 | 6.49 | 7.42 | 7.40 | 7.92 | 8.55 | 9.49 | 10.29 | 10.06 | 10.51 |
| Parenteral | 5.39 | 5.25 | 5.62 | 5.99 | 7.22 | 7.15 | 7.43 | 8.30 | 8.32 | 8.65 | 8.68 |
| Other | 4.15 | 4.62 | 5.17 | 4.63 | 4.25 | 4.91 | 5.12 | 4.60 | 5.36 | 5.90 | 7.50 |
Respiratory Drug Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.41 | 1.68 | 1.95 | 2.43 | 2.43 | 1.91 | 2.66 | 3.10 | 3.33 | 3.37 | 3.78 |
| Europe | 5.52 | 6.78 | 7.89 | 8.19 | 8.24 | 9.15 | 9.39 | 9.80 | 10.59 | 11.44 | 11.54 |
| Asia Pacific | 4.89 | 5.52 | 5.65 | 5.96 | 6.29 | 6.56 | 6.91 | 6.98 | 7.40 | 8.55 | 8.54 |
| Latin America | 0.47 | 0.26 | 0.19 | 0.20 | 0.85 | 0.78 | 0.45 | 0.69 | 0.92 | 0.81 | 1.56 |
| Middle East & Africa | 4.24 | 4.30 | 3.94 | 3.99 | 4.15 | 4.84 | 5.18 | 5.45 | 5.29 | 4.95 | 5.39 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
